Søren Lykke Petersen

Improved Overall Survival, Relapse-Free-Survival, and Less Graft-vs.-Host-Disease in Patients With High Immune Reconstitution of TCR Gamma Delta Cells 2 Months After Allogeneic Stem Cell Transplantation

Lia Minculescu, Hanne Vibeke Marquart, Lars P. Ryder et al. · Frontiers in Immunology · 2019 · 65 citations · Full text

Association of HMGB1 Polymorphisms with Outcome after Allogeneic Hematopoietic Cell Transplantation

Brian Kornblit, Tania Nicole Masmas, Søren Lykke Petersen et al. · Biology of Blood and Marrow Transplantation · 2009 · 48 citations

Hmgb1 Polymorphisms, Transplantation, Genetics +9

Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.

Søren Lykke Petersen · PubMed · 2007 · 46 citations

Cell Therapy, Immunology, Nonmyeloablative Conditioning +20

Allogeneic hematopoietic cell transplantation with non-myeloablative conditioning for patients with hematologic malignancies: Improved outcomes over two decades

Jason P. Cooper, Barry E. Storer, Noa Granot et al. · Haematologica · 2020 · 35 citations · Full text

Haematopoietic stem cell transplantation with non‐myeloablative conditioning in the outpatient setting: results, complications and admission requirements in a single institution

Søren Lykke Petersen, Hans O. Madsen, Lars P. Ryder et al. · British Journal of Haematology · 2004 · 31 citations · Full text